Vaccination with autologous dendritic cells pulsed with allogeneic tumour lysate (MelCancerVac) for the treatment of patients with advanced or metastatic non-small cell lung cancer. A phase II study
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2012
At a glance
- Drugs Celecoxib; Melanoma vaccine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2007 New trial record.